MAPT and Dravet syndrome: These results demonstrate that F127-Bdph shares an activity similar to DAPT in reducing amyloid aggregates and also has a stronger therapeutic effect on ameliorating the abnormality of Tau production and hyperphosphorylation in DS neurons.